316 related articles for article (PubMed ID: 21624751)
1. The opposing role of two prostaglandin D2 receptors, DP and CRTH2, in human eosinophil migration.
Chiba T; Ueki S; Ito W; Kato H; Kamada R; Takeda M; Kayaba H; Furue M; Chihara J
Ann Allergy Asthma Immunol; 2011 Jun; 106(6):511-7. PubMed ID: 21624751
[TBL] [Abstract][Full Text] [Related]
2. Differential modulation of human basophil functions through prostaglandin D2 receptors DP and chemoattractant receptor-homologous molecule expressed on Th2 cells/DP2.
Yoshimura-Uchiyama C; Iikura M; Yamaguchi M; Nagase H; Ishii A; Matsushima K; Yamamoto K; Shichijo M; Bacon KB; Hirai K
Clin Exp Allergy; 2004 Aug; 34(8):1283-90. PubMed ID: 15298571
[TBL] [Abstract][Full Text] [Related]
3. Prostaglandin H2 induces the migration of human eosinophils through the chemoattractant receptor homologous molecule of Th2 cells, CRTH2.
Schuligoi R; Sedej M; Waldhoer M; Vukoja A; Sturm EM; Lippe IT; Peskar BA; Heinemann A
J Leukoc Biol; 2009 Jan; 85(1):136-45. PubMed ID: 18835884
[TBL] [Abstract][Full Text] [Related]
4. CRTH2 and D-type prostanoid receptor antagonists as novel therapeutic agents for inflammatory diseases.
Schuligoi R; Sturm E; Luschnig P; Konya V; Philipose S; Sedej M; Waldhoer M; Peskar BA; Heinemann A
Pharmacology; 2010; 85(6):372-82. PubMed ID: 20559016
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effect of the 4-aminotetrahydroquinoline derivatives, selective chemoattractant receptor-homologous molecule expressed on T helper 2 cell antagonists, on eosinophil migration induced by prostaglandin D2.
Mimura H; Ikemura T; Kotera O; Sawada M; Tashiro S; Fuse E; Ueno K; Manabe H; Ohshima E; Karasawa A; Miyaji H
J Pharmacol Exp Ther; 2005 Jul; 314(1):244-51. PubMed ID: 15798001
[TBL] [Abstract][Full Text] [Related]
6. Cutting edge: chemoattractant receptor-homologous molecule expressed on Th2 cells plays a restricting role on IL-5 production and eosinophil recruitment.
Chevalier E; Stock J; Fisher T; Dupont M; Fric M; Fargeau H; Leport M; Soler S; Fabien S; Pruniaux MP; Fink M; Bertrand CP; McNeish J; Li B
J Immunol; 2005 Aug; 175(4):2056-60. PubMed ID: 16081770
[TBL] [Abstract][Full Text] [Related]
7. Antagonists of the prostaglandin D2 receptor CRTH2.
Pettipher R; Hansel TT
Drug News Perspect; 2008; 21(6):317-22. PubMed ID: 18836589
[TBL] [Abstract][Full Text] [Related]
8. Production of prostaglandin D(2) by human osteoblasts and modulation of osteoprotegerin, RANKL, and cellular migration by DP and CRTH2 receptors.
Gallant MA; Samadfam R; Hackett JA; Antoniou J; Parent JL; de Brum-Fernandes AJ
J Bone Miner Res; 2005 Apr; 20(4):672-81. PubMed ID: 15765187
[TBL] [Abstract][Full Text] [Related]
9. Pharmacologic profile of OC000459, a potent, selective, and orally active D prostanoid receptor 2 antagonist that inhibits mast cell-dependent activation of T helper 2 lymphocytes and eosinophils.
Pettipher R; Vinall SL; Xue L; Speight G; Townsend ER; Gazi L; Whelan CJ; Armer RE; Payton MA; Hunter MG
J Pharmacol Exp Ther; 2012 Feb; 340(2):473-82. PubMed ID: 22106101
[TBL] [Abstract][Full Text] [Related]
10. Selective modulation of chemokinesis, degranulation, and apoptosis in eosinophils through the PGD2 receptors CRTH2 and DP.
Gervais FG; Cruz RP; Chateauneuf A; Gale S; Sawyer N; Nantel F; Metters KM; O'neill GP
J Allergy Clin Immunol; 2001 Dec; 108(6):982-8. PubMed ID: 11742277
[TBL] [Abstract][Full Text] [Related]
11. Possible novel receptor for PGD2 on human bronchial epithelial cells.
Chiba T; Kanda A; Ueki S; Ito W; Yamaguchi K; Kamada Y; Takeda M; Tanigai T; Oyamada H; Kayaba H; Chihara J
Int Arch Allergy Immunol; 2007; 143 Suppl 1():23-7. PubMed ID: 17541272
[TBL] [Abstract][Full Text] [Related]
12. IFN-γ and TNF-α potentiate prostaglandin D2-induced human eosinophil chemotaxis through up-regulation of CRTH2 surface receptor.
El-Shazly AE; Moonen V; Mawet M; Begon D; Henket M; Arafa M; Louis R; Delvenne P; Lefebvre PP
Int Immunopharmacol; 2011 Nov; 11(11):1864-70. PubMed ID: 21835268
[TBL] [Abstract][Full Text] [Related]
13. Delta12-prostaglandin D2 is a potent and selective CRTH2 receptor agonist and causes activation of human eosinophils and Th2 lymphocytes.
Gazi L; Gyles S; Rose J; Lees S; Allan C; Xue L; Jassal R; Speight G; Gamble V; Pettipher R
Prostaglandins Other Lipid Mediat; 2005 Jan; 75(1-4):153-67. PubMed ID: 15789622
[TBL] [Abstract][Full Text] [Related]
14. D-type prostanoid receptor enhances the signaling of chemoattractant receptor-homologous molecule expressed on T(H)2 cells.
Sedej M; Schröder R; Bell K; Platzer W; Vukoja A; Kostenis E; Heinemann A; Waldhoer M
J Allergy Clin Immunol; 2012 Feb; 129(2):492-500, 500.e1-9. PubMed ID: 21930295
[TBL] [Abstract][Full Text] [Related]
15. Chemoattractant receptor-homologous molecule expressed on Th2 cells activation in vivo increases blood leukocyte counts and its blockade abrogates 13,14-dihydro-15-keto-prostaglandin D2-induced eosinophilia in rats.
Shichijo M; Sugimoto H; Nagao K; Inbe H; Encinas JA; Takeshita K; Bacon KB; Gantner F
J Pharmacol Exp Ther; 2003 Nov; 307(2):518-25. PubMed ID: 12975488
[TBL] [Abstract][Full Text] [Related]
16. Prostaglandin D2-induced eosinophilic airway inflammation is mediated by CRTH2 receptor.
Shiraishi Y; Asano K; Nakajima T; Oguma T; Suzuki Y; Shiomi T; Sayama K; Niimi K; Wakaki M; Kagyo J; Ikeda E; Hirai H; Yamaguchi K; Ishizaka A
J Pharmacol Exp Ther; 2005 Mar; 312(3):954-60. PubMed ID: 15528449
[TBL] [Abstract][Full Text] [Related]
17. A novel antagonist of prostaglandin D2 blocks the locomotion of eosinophils and basophils.
Royer JF; Schratl P; Carrillo JJ; Jupp R; Barker J; Weyman-Jones C; Beri R; Sargent C; Schmidt JA; Lang-Loidolt D; Heinemann A
Eur J Clin Invest; 2008 Sep; 38(9):663-71. PubMed ID: 18837743
[TBL] [Abstract][Full Text] [Related]
18. Prostaglandin D2 causes preferential induction of proinflammatory Th2 cytokine production through an action on chemoattractant receptor-like molecule expressed on Th2 cells.
Xue L; Gyles SL; Wettey FR; Gazi L; Townsend E; Hunter MG; Pettipher R
J Immunol; 2005 Nov; 175(10):6531-6. PubMed ID: 16272307
[TBL] [Abstract][Full Text] [Related]
19. Chemotactic responses of peripheral blood eosinophils to prostaglandin D2 in atopic keratoconjunctivitis.
Fujishima H; Fukagawa K; Okada N; Takano Y; Hirai H; Nagata K; Hashida R; Matsumoto K; Saito H
Ann Allergy Asthma Immunol; 2013 Aug; 111(2):126-131.e4. PubMed ID: 23886231
[TBL] [Abstract][Full Text] [Related]
20. Agonist and antagonist effects of 15R-prostaglandin (PG) D2 and 11-methylene-PGD2 on human eosinophils and basophils.
Cossette C; Walsh SE; Kim S; Lee GJ; Lawson JA; Bellone S; Rokach J; Powell WS
J Pharmacol Exp Ther; 2007 Jan; 320(1):173-9. PubMed ID: 17041009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
